Shandong Xinhua Pharmaceutical Company Limited (HKG: 0719)

Shandong Xinhua Pharmaceutical Company Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 2, 2025	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	10,787	11,897	17,740	6,846	5,447	4,336
Market Cap Growth	-10.11%	-32.94%	159.14%	25.67%	25.64%	27.25%
Enterprise Value	11,588	12,706	17,708	8,175	6,459	5,408
Last Close Price	6.36	5.46	7.41	4.12	3.01	3.14
PE Ratio	8.83	21.75	38.17	16.00	14.12	12.92
PS Ratio	0.47	1.33	2.09	0.85	0.76	0.69
PB Ratio	0.80	2.26	3.61	1.53	1.35	1.25
P/TBV Ratio	2.12	2.66	4.30	1.86	1.65	1.52
P/FCF Ratio	23.18	-	30.56	563.90	32.76	-
P/OCF Ratio	20.93	40.71	20.70	21.52	10.92	11.13
EV/Sales Ratio	1.25	1.42	2.09	1.02	0.91	0.86
EV/EBITDA Ratio	10.37	11.27	16.45	7.93	6.45	6.59
EV/EBIT Ratio	21.94	22.52	33.62	16.50	11.85	12.39
EV/FCF Ratio	61.89	-	30.51	673.39	38.85	-
Debt / Equity Ratio	0.33	0.28	0.32	0.45	0.49	0.49
Debt / EBITDA Ratio	1.64	1.32	1.45	1.95	1.95	2.08
Debt / FCF Ratio	9.80	-	2.70	166.46	11.75	-
Asset Turnover	1.00	0.98	0.96	0.91	0.89	0.91
Inventory Turnover	5.66	4.58	4.92	4.48	3.76	3.64
Quick Ratio	0.84	0.76	0.68	0.65	0.59	0.47
Current Ratio	1.34	1.33	1.09	1.10	1.13	0.98
Return on Equity (ROE)	9.42%	11.09%	10.65%	10.28%	10.68%	10.91%
Return on Assets (ROA)	3.56%	3.87%	3.73%	3.50%	4.24%	3.94%
Return on Capital (ROIC)	4.65%	5.39%	5.28%	4.88%	5.93%	5.49%
Earnings Yield	4.84%	4.60%	2.62%	6.25%	7.08%	7.74%
FCF Yield	1.82%	-0.55%	3.27%	0.18%	3.05%	-0.47%
Dividend Yield	0.89%	5.05%	3.05%	4.47%	5.92%	4.28%
Payout Ratio	49.97%	35.43%	39.66%	42.59%	39.05%	38.80%
Buyback Yield / Dilution	-0.91%	-3.20%	-6.92%	0.02%	-0.86%	0.14%
Total Shareholder Return	-0.02%	1.85%	-3.87%	4.48%	5.06%	4.41%

Source: S&P Capital IQ. Standard template. Financial Sources.